Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice
- PMID: 16497988
- DOI: 10.1161/01.RES.0000215809.47923.fd
Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice
Abstract
Heterozygous germline mutations in the gene encoding the bone morphogenetic protein type II (BMPR-II) receptor underlie the majority (>70%) of cases of familial pulmonary arterial hypertension (FPAH), and dysfunction of BMP signaling has been implicated in other forms of PAH. The reduced disease gene penetrance in FPAH indicates that other genetic and/or environmental factors may also be required for the clinical manifestation of disease. Of these, the serotonin pathway has been implicated as a major factor in PAH pathogenesis. We investigated the pulmonary circulation of mice deficient in BMPR-II (BMPR2(+/-) mice) and show that pulmonary hemodynamics and vascular morphometry of BMPR2(+/-) mice were similar to wild-type littermate controls under normoxic or chronic hypoxic (2- to 3-week) conditions. However, chronic infusion of serotonin caused increased pulmonary artery systolic pressure, right ventricular hypertrophy, and pulmonary artery remodeling in BMPR2(+/-) mice compared with wild-type littermates, an effect that was exaggerated under hypoxic conditions. In addition, pulmonary, but not systemic, resistance arteries from BMPR2(+/-) mice exhibited increased contractile responses to serotonin mediated by both 5-HT2 and 5-HT1 receptors. Furthermore, pulmonary artery smooth muscle cells from BMPR2(+/-) mice exhibited a heightened DNA synthesis and activation of extracellular signal-regulated kinase 1/2 in response to serotonin compared with wild-type cells. In vitro and in vivo experiments suggested that serotonin inhibits BMP signaling via Smad proteins and the expression of BMP responsive genes. These findings provide the first evidence for an interaction between BMPR-II-mediated signaling and the serotonin pathway, perturbation of which may be critical to the pathogenesis of PAH.
Similar articles
-
Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension.Circ Res. 2005 May 27;96(10):1053-63. doi: 10.1161/01.RES.0000166926.54293.68. Epub 2005 Apr 21. Circ Res. 2005. PMID: 15845886
-
Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension.Circ Res. 2006 Feb 3;98(2):209-17. doi: 10.1161/01.RES.0000200180.01710.e6. Epub 2005 Dec 15. Circ Res. 2006. PMID: 16357305
-
Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.Hypertens Res. 2010 May;33(5):435-45. doi: 10.1038/hr.2010.16. Epub 2010 Feb 26. Hypertens Res. 2010. PMID: 20186146
-
Pulmonary hypertension due to BMPR2 mutation: a new paradigm for tissue remodeling?Proc Am Thorac Soc. 2006 Nov;3(8):680-6. doi: 10.1513/pats.200605-118SF. Proc Am Thorac Soc. 2006. PMID: 17065373 Review.
-
The transforming growth factor-β-bone morphogenetic protein type signalling pathway in pulmonary vascular homeostasis and disease.Exp Physiol. 2013 Aug;98(8):1262-6. doi: 10.1113/expphysiol.2012.069104. Epub 2013 May 3. Exp Physiol. 2013. PMID: 23645549 Review.
Cited by
-
Bone morphogenetic protein receptor type II deficiency and increased inflammatory cytokine production. A gateway to pulmonary arterial hypertension.Am J Respir Crit Care Med. 2015 Oct 1;192(7):859-72. doi: 10.1164/rccm.201408-1509OC. Am J Respir Crit Care Med. 2015. PMID: 26073741 Free PMC article.
-
Pulmonary Arterial Hypertension: Emerging Principles of Precision Medicine across Basic Science to Clinical Practice.Rev Cardiovasc Med. 2022;23(11):378. doi: 10.31083/j.rcm2311378. Epub 2022 Nov 9. Rev Cardiovasc Med. 2022. PMID: 36875282 Free PMC article.
-
Bone morphogenetic protein 2 induces pulmonary angiogenesis via Wnt-beta-catenin and Wnt-RhoA-Rac1 pathways.J Cell Biol. 2009 Jan 12;184(1):83-99. doi: 10.1083/jcb.200806049. J Cell Biol. 2009. PMID: 19139264 Free PMC article.
-
BMP4 increases the expression of TRPC and basal [Ca2+]i via the p38MAPK and ERK1/2 pathways independent of BMPRII in PASMCs.PLoS One. 2014 Dec 2;9(12):e112695. doi: 10.1371/journal.pone.0112695. eCollection 2014. PLoS One. 2014. PMID: 25461595 Free PMC article.
-
Pediatric Pulmonary Hypertension: Definitions, Mechanisms, Diagnosis, and Treatment.Compr Physiol. 2021 Jun 30;11(3):2135-2190. doi: 10.1002/cphy.c200023. Compr Physiol. 2021. PMID: 34190343 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous